ArticleCell death & disease2021

Glycogen synthase kinase 3β inhibition synergizes with PARP inhibitors through the induction of homologous recombination deficiency in colorectal cancer.

Ning Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.